PT  - JOURNAL ARTICLE
ED  - ,
TI  - Endpoints in asthma drug trials - what do they mean?
AID  - 10.1136/dtb.2006.44321
DP  - 2006 Mar 01
TA  - Drug and Therapeutics Bulletin
PG  - 21--24
VI  - 44
IP  - 3
4099  - http://dtb.bmj.com/content/44/3/21.short
4100  - http://dtb.bmj.com/content/44/3/21.full
SO  - Drug Ther Bull2006 Mar 01; 44
AB  - There are many potential outcomes or endpoints to choose from to assess the effects of asthma treatments, and a wide range of such measures are used in different trials. This can make it difficult to compare treatment outcomes from different trials and to understand whether new treatments offer a genuine clinical benefit for patients. Here we review the common endpoints used in trials to assess the efficacy of asthma treatments.